trending Market Intelligence /marketintelligence/en/news-insights/trending/upV3Nx4TFSbzGhbA4OycKw2 content esgSubNav
In This List

1315 Capital acquires medical device coating manufacturer Biocoat

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


1315 Capital acquires medical device coating manufacturer Biocoat

Healthcare investment firm 1315 Capital LLC purchased Biocoat Inc. for an undisclosed amount.

The acquired company provides contract and original equipment manufacturers with hydrophilic biomaterial coatings for medical devices used in the neurovascular, cardiovascular, peripheral and ophthalmic markets. The acquisition is expected to help Biocoat further expand its research and development efforts and reach more customers.

Philadelphia-based 1315 Capital invests in commercial-stage healthcare services, medical technology and specialty pharmaceutical companies.